Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 23.12.2018 1 AJR Am J Roentgenol 1 Am J Pathol 4 Dig Dis Sci 6 Eur Radiol 1 Gastroenterology 7 Hepatology 1 J Clin Oncol 2 J Gastroenterol Hepatol 3 J Hepatol 2 Lancet 1 PLoS One 1 Proc Natl Acad Sci U S A 7 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. CANNELLA R, Rangaswamy B, Minervini MI, Borhani AA, et al
   Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
   AJR Am J Roentgenol. 2018 Dec 17:1-9. doi: 10.2214/AJR.18.20182.
   PubMed     Text format     Abstract available
   
   

   
   Am J Pathol

2. PALMA E, Ma X, Riva A, Iansante V, et al
   Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity.
   Am J Pathol. 2018 Dec 13. pii: S0002-9440(18)30112.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

3. STINE JG, Northup PG
   Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.
   Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5427.
   PubMed     Text format     Abstract available
   
   
4. KAKAR S, Dugum M, Cabello R, Humar A, et al
   Incidence of Recurrent NASH-Related Allograft Cirrhosis.
   Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5413.
   PubMed     Text format     Abstract available
   
   
5. MAIMONE S, Saffioti F, Filomia R, Alibrandi A, et al
   Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
   Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5412.
   PubMed     Text format     Abstract available
   
   
6. HUANG X, Gao Y, Qin J, Lu S, et al
   miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.
   Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5405.
   PubMed     Text format     Abstract available
   
   

   
   Eur Radiol

7. LEE HS, Kim MJ, An C
   How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
   Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5893.
   PubMed     Text format     Abstract available
   
   
8. PARK YS, Lee J, Kim JW, Park CM, et al
   Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.
   Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5897.
   PubMed     Text format     Abstract available
   
   
9. RHEE H, Kim MJ, Park YN, An C, et al
   A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
   Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5898.
   PubMed     Text format     Abstract available
   
   
10. TANG A, Destrempes F, Kazemirad S, Garcia-Duitama J, et al
    Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5915.
    PubMed     Text format     Abstract available
    
    
11. UHLIG J, Sellers CM, Stein SM, Kim HS, et al
    Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5902.
    PubMed     Text format     Abstract available
    
    
12. BYUN J, Lee SS, Sung YS, Shin Y, et al
    CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
    Eur Radiol. 2018 Dec 19. pii: 10.1007/s00330-018-5905.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

13. PIANO S, Singh V, Caraceni P, Maiwall R, et al
    Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Gastroenterology. 2018 Dec 12. pii: S0016-5085(18)35402.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

14. YANG JD, Patel T
    Early Detection of Hepatocellular Carcinoma - Expanding the Utility of Circulating Tumor Markers.
    Hepatology. 2018 Dec 17. doi: 10.1002/hep.30468.
    PubMed     Text format     Abstract available
    
    
15. ZUO X, Chen Z, Cai J, Gao W, et al
    5-hydroxytryptamine receptor 1D aggravates hepatocellular carcinoma progression via FoxO6 in AKT-dependent and independent manners.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30430.
    PubMed     Text format     Abstract available
    
    
16. RIVEIRO-BARCIELA M, Gironella M, Senin A, Salcedo MT, et al
    Decompensated liver disease due to primary hepatic amyloidosis: Is liver transplantation still mandatory?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30464.
    PubMed     Text format     Abstract available
    
    
17. LEE D, Xu IM, Chiu DK, Leibold J, et al
    Induction of Oxidative Stress via Inhibition of Thioredoxin Reductase 1 is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30467.
    PubMed     Text format     Abstract available
    
    
18. CHEHADE S, Adams PC
    Severe hemochromatosis arthropathy in the absence of iron overload.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30469.
    PubMed     Text format     Abstract available
    
    
19. SALMON-CERON D, Nahon P, Layese R, Bourcier V, et al
    HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients.
    Hepatology. 2018 Dec 19. doi: 10.1002/hep.30400.
    PubMed     Text format     Abstract available
    
    
20. COTTER TG, Charlton M
    The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality from Cirrhosis.
    Hepatology. 2018 Dec 20. doi: 10.1002/hep.30408.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

21. PINATO DJ, Allara E, Chen TY, Trevisani F, et al
    Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
    J Clin Oncol. 2018 Dec 18:JCO1800885. doi: 10.1200/JCO.18.00885.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

22. ASPELUND G, Mahdi EM, Rothstein DH, Wakeman DS, et al
    Transitional care for patients with surgical pediatric hepatobiliary disease: choledochal cysts and biliary atresia.
    J Gastroenterol Hepatol. 2018 Dec 15. doi: 10.1111/jgh.14575.
    PubMed     Text format     Abstract available
    
    
23. LOPEZ RN, Al Rawahi Y, Stormon M, Chennapragada M, et al
    Hepatobiliary and Pancreatic: Hepatic arterioportal fistula: A novel and treatable feature of Alagille syndrome.
    J Gastroenterol Hepatol. 2018 Dec 18. doi: 10.1111/jgh.14506.
    PubMed     Text format    
    
    

    
    J Hepatol

24. DE OLIVEIRA S, Houseright RA, Graves AL, Golenberg N, et al
    Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    J Hepatol. 2018 Dec 17. pii: S0168-8278(18)32622.
    PubMed     Text format     Abstract available
    
    
25. KUSAKABE J, Firl DJ, Sasaki K
    Toward the universal scoring system in treatment for patients with hepatocellular carcinoma.
    J Hepatol. 2018 Dec 13. pii: S0168-8278(18)32508.
    PubMed     Text format    
    
    
26. ZHANG XY, Ou J, Chen JY, Li WW, et al
    Predicting early hepatocellular carcinoma recurrence after resection: A comment for moving forward.
    J Hepatol. 2018 Dec 13. pii: S0168-8278(18)32491.
    PubMed     Text format    
    
    

    
    Lancet

27. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Text format     Abstract available
    
    
28. WONG VWS, Adams LA
    Fibroblast growth factor 21 for non-alcoholic steatohepatitis.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)32165.
    PubMed     Text format    
    
    

    
    PLoS One

29. LUDWIG JM, Zhang Y, Chamulitrat W, Stremmel W, et al
    Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
    PLoS One. 2018;13:e0197836.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. DOW M, Pyke RM, Tsui BY, Alexandrov LB, et al
    Integrative genomic analysis of mouse and human hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2018;115:E9879-E9888.
    PubMed     Text format     Abstract available
    
    

    
    Semin Liver Dis

31. YANG L, Wu T, Li J, Li J, et al
    Bacterial Infections in Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2018;38:121-133.
    PubMed     Text format     Abstract available
    
    
32. LESAFFRE E
    Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.
    Semin Liver Dis. 2018;38:97-102.
    PubMed     Text format     Abstract available
    
    
33. ALFERINK LJM, Kiefte-de Jong JC, Darwish Murad S
    Potential Mechanisms Underlying the Role of Coffee in Liver Health.
    Semin Liver Dis. 2018;38:193-214.
    PubMed     Text format     Abstract available
    
    
34. LALAZAR G, Simon SM
    Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
    Semin Liver Dis. 2018;38:51-59.
    PubMed     Text format     Abstract available
    
    
35. MANN JP, Valenti L, Scorletti E, Byrne CD, et al
    Nonalcoholic Fatty Liver Disease in Children.
    Semin Liver Dis. 2018;38:1-13.
    PubMed     Text format     Abstract available
    
    
36. SHI SH, Zhai ZL, Zheng SS
    Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies.
    Semin Liver Dis. 2018;38:270-283.
    PubMed     Text format     Abstract available
    
    
37. DARA L
    The Receptor Interacting Protein Kinases in the Liver.
    Semin Liver Dis. 2018;38:73-86.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: